Agenus, 10% Owner of MiNK Therapeutics INKT, has filed 13 purchases and 0 sales on the open market. The latest trade was on 23/10/16.

Agenus

10% Owner

Company

MiNK Therapeutics INKT

First filing

23/05/03

Trades

15 trades

Buys / sales

13 / 0

12-month net buying

No record

Last trade

23/10/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
MiNK TherapeuticsINKT	Open-market buy	23/10/12–23/10/16	23/10/16	22,975 sh3 trades	$1.10avg.	$25,272.5	+0.1%
MiNK TherapeuticsINKT	Open-market buy	23/10/04	23/10/06	15,001 sh	$1.09	$16,351.09	+0.1%
MiNK TherapeuticsINKT	Open-market buy	23/08/29	23/08/31	29,678 sh	$1.52	$45,110.56	+0.1%
MiNK TherapeuticsINKT	Open-market buy	23/08/24–23/08/28	23/08/28	183,052 sh2 trades	$1.53avg.	$280,747.36	+0.9%
MiNK TherapeuticsINKT	Open-market buy	23/05/10–23/05/11	23/05/12	45,426 sh2 trades	$1.47avg.	$66,724.38	+0.2%
MiNK TherapeuticsINKT	Open-market buy	23/05/03–23/05/05	23/05/05	250,362 sh4 trades	$1.04avg.	$260,431.18	+1.2%